Related Experiment Videos
[Dibekacin treatment of infectious complications of abdominal surgery]
Abstract:
Major abdominal surgery often involves severe postoperative infections with various pathogens: enterobacteriaceae, staphylococcus and anaerobic bacteria. For this reason a strong antibiotherapy can be necessary in the case of an infectious disease. Dibekacin was administered at a daily dose of 3 mg/kg to 22 patients suffering from very severe postoperative infection. In all the cases dibekacin was combined with a beta-lactamine and in some with nitro-imidazole derivative. The results were especially favourable in all of these cases and a good tolerance was observed.
Insights
Severe postoperative infections following abdominal surgery require potent antibiotics. Dibekacin, combined with other agents, demonstrated favorable outcomes and good tolerance in 22 patients with severe infections.
Area of Science:
- Clinical microbiology
- Infectious diseases
- Pharmacology
Context:
- Postoperative infections are a significant complication of major abdominal surgery.
- Common pathogens include Enterobacteriaceae, Staphylococcus, and anaerobic bacteria.
- Effective antibiotic therapy is crucial for managing severe infections.
Purpose:
- To evaluate the efficacy and tolerance of dibekacin in treating severe postoperative infections.
- To assess the use of dibekacin in combination with beta-lactamines and nitro-imidazole derivatives.
Summary:
- Dibekacin was administered at 3 mg/kg daily to 22 patients with severe postoperative infections.
- The antibiotic was used in combination with a beta-lactamine, and in some cases, a nitro-imidazole derivative.
- Favorable clinical results and good patient tolerance were observed in all treated cases.
Impact:
- Highlights the potential of dibekacin as a therapeutic option for severe postoperative infections.
- Suggests the effectiveness of combination therapy involving dibekacin.
- Provides evidence for the good tolerability of dibekacin in a clinical setting.